MIRA INFORM REPORT

 

 

Report No. :

313618

Report Date :

30.03.2015

 

IDENTIFICATION DETAILS

 

Name :

RECKITT BENCKISER (INDIA) LIMITED

 

 

Registered Office :

227 Okhla Industrial Estate, Phase III, New Delhi – 110020

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

05.07.1951

 

 

Com. Reg. No.:

55-127062

 

 

Capital Investment / Paid-up Capital :

Rs.258.725 Million

 

 

CIN No.:

[Company Identification No.]

U74999DL1951PLC127062

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

RTKR01561A

 

 

PAN No.:

[Permanent Account No.]

AABCR2655Q

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer, seller and exporter of drugs and medicines, such as bulk drugs in the form of liquids, ointments, and tablets; denture products; food products, including tea, cashew kernels, and mushrooms; laundry products; household products; aromatic chemicals; and toiletries.

 

 

No. of Employees :

Not Available 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (69)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 52000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subjects is a part of “Reckitt Benckiser Plc, UK”. It is a well-established company having fine track.

 

 The company possesses a healthy financial profile marked by favourable net worth base and sound liquidity position owing to zero debt position further strengthening the capital structure along with sufficient cash balance.

 

Management has reported a decent sales volume as well as net profitability, backed by adequate margins during FY 2014.

 

The ratings also take into consideration the growth in the business profile, resulting into gaining third spot in the Indian home and personal care market.

 

Trade relations are fair. Business is active. Payment terms are reported as regular and as per commitments.

 

In view of technical, managerial and financial support extended from the parent, the company can be considered for business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DECLINED

 

Management non co-operative

 

 

LOCATIONS

 

Registered Office :

227 Okhla Industrial Estate, Phase III, New Delhi – 110020, India

Tel. No.:

91-124-4028000 / 3319000

Mobile No.:

Not Available

Fax No.:

91-124-4340110

E-Mail :

Legal.India@rb.com

Manoj.Bisht@rb.com

Website :

http://www.reckittbenckiser.com

 

 

Corporate Office :

Enkay Centre, 2nd Floor, Vanijya Nikunj, Udyog Vihar, Phase V, Gurgaon -122016, Haryana, India

Tel. No.:

91-124-2398200/2398209

Fax No.:

91-124-2398230/2398231/2398232

 

 

Factory 1 :

25, Ho Chi Minh Sarani, Behala, Kolkata - 700 061, West Bengal, India

Tel. No.:

 91-33-2493 4079 / 4717

Fax No.:

 91-33-2493 3529

 

 

Factory 2 :

20/1, Chetla Road, Kolkata - 700 027, West Bengal, India

Tel. No.:

 91-33-2479 8361 / 8362

 

 

Factory 3 :

P. O. Kalla, Central Hospital, Dhadka, Asansol - 713 340, West Bengal, India

Tel. No.:

 91-341-2202521 / 2204683

Fax No.:

 91-341-2209788

 

 

Factory 4 :

61-62, Hootagalli Estate, Mysore - 571 186, Karnataka, India

Tel. No.:

 91-821-2402509 / 2402520

Fax No.:

91-821-2402758

 

 

Factory 5 :

Plot No. 176, SIPCOT Hosur Industrial Area, Hosur - 635 126, Tamilnadu, India

Tel. No.:

91-4344-276661 / 276490

Fax No.:

91-4344-276662 / 277205

 

 

Factory 6 :

B-4/10, Asaf Ali Road, New Delhi – 110 002

Tel. No.:

91-11-23272121

Fax No.:

91-11-23281662

 

 

Factory 7 :

Mahalaxmi Chambers, 29, Mahatma Gandhi Road, Bangalore – 560 001, Karnataka, India

Tel. No.:

91-80-25584614

Fax No.:

91-80-25584738

 

 

Factory 8 :

107-111, Nirman Kendra, 1st Floor, Dr. E. Mosses Road, Near Famous Studio, Mahalaxmi, Mumbai – 400 011, Maharashtra, India

Tel. No.:

91-22-24965840

Fax No.:

91-22-24980801

 

 

Factory 9 :

41, Chowringhee Road, Kolkata – 700 071, West Bengal, India

Tel. No.:

91-33-22886850

Fax No.:

91-33-22888085

 

 

Factory 10:

Plot No.48, Institutional Area, Sector 32, Gurgaon – 122001, Haryana, India

Tel. No.:

91-124-4028000 / 3319000

Fax No.:

91-124-4340110

 

 

DIRECTORS

 

As on : 30.09.2014

 

Name :

Mr. Gopal Mishra

Designation :

Whole Time Director

Address :

Flat No. 1702, JMD Garden, Sector – 33, Sohna Road, Gurgaon, India

Date of Birth/Age :

28.01.1972

Date of Appointment :

15.11.2012

DIN No.:

06418731

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231HR1980PLC044172

RECKITT BENCKISER HEALTHCARE INDIA LIMITED

Director

28/06/2013

15/11/2012

-

Active

NO

2

U74999DL1951PLC127062

RECKITT BENCKISER (INDIA) LIMITED

Whole-time director

15/11/2012

15/11/2012

-

Active

NO

3

U24232TN1994PLC048002

RECKITT BENCKISER SCHOLL INDIA LIMITED

Director

26/06/2013

09/05/2013

-

Active

NO

 

 

Name :

Mr. Rajesh Kumar Jha

Designation :

Whole Time Director

Address :

C-3, 3164, Vasant Kunj, New Delhi – 110070, Delhi

Date of Birth/Age :

30.06.1968

Date of Appointment :

04.11.2013

DIN No.:

02695721

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239MH1997PTC111897

RECKITT PIRAMAL PRIVATE LIMITED

Director

27/05/2010

10/08/2009

-

Active

NO

2

U65993HR2011PTC042069

Reckitt Benckiser Investments India Private Limited

Additional director

28/03/2011

28/03/2011

-

Amalgamated

NO

3

U24240MH2011PTC239427

Halite Personal Care India Private Limited

Additional director

11/08/2011

11/08/2011

29/05/2012

Under liquidation

NO

4

U24231HR1980PLC044172

RECKITT BENCKISER HEALTHCARE INDIA LIMITED

Director

28/06/2013

16/08/2011

-

Active

NO

5

U24232TN1994PLC048002

RECKITT BENCKISER SCHOLL INDIA LIMITED

Director

03/10/2011

03/10/2011

-

Active

NO

6

U74999DL1951PLC127062

RECKITT BENCKISER (INDIA) LIMITED

Whole-time director

04/11/2013

02/01/2012

-

Active

NO

 

 

Name :

Mr. Sreenivasrao Nasdigam

Designation :

Whole Time Director

Address :

CI 301, Uniworld City, DLF Phase 4, Gurgaon – 122002, Haryana, India

Date of Birth/Age :

24.04.1969

Date of Appointment :

04.11.2013

DIN No.:

02410352

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74999DL1951PLC127062

RECKITT BENCKISER (INDIA) LIMITED

Whole-time director

04/11/2013

17/12/2008

-

Active

NO

2

U24231HR1980PLC044172

RECKITT BENCKISER HEALTHCARE INDIA LIMITED

Director

21/09/2011

11/04/2011

05/01/2012

Active

NO

3

U24232TN1994PLC048002

RECKITT BENCKISER SCHOLL INDIA LIMITED

Alternate director

24/06/2011

24/06/2011

03/10/2011

Active

NO

 

Name :

Mr. Nitish Kapoor

Designation :

Managing Director

Address :

102/97, Silver Oaks Aptts DLF – 1, Gurgaon – 122002, Haryana, India

Date of Birth/Age :

04.03.1968

Date of Appointment :

03.01.2014

DIN No.:

06767690

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74999DL1951PLC127062

RECKITT BENCKISER (INDIA) LIMITED

Managing director

03/01/2014

03/01/2014

-

Active

NO

2

U24231HR1980PLC044172

RECKITT BENCKISER HEALTHCARE INDIA LIMITED

Managing director

03/01/2014

03/01/2014

-

Active

NO

3

U24232TN1994PLC048002

RECKITT BENCKISER SCHOLL INDIA LIMITED

Director

25/09/2014

23/06/2014

-

Active

NO

 

Name :

Mr. Chander Mohan Sethi

Designation :

Director

Address :

302 B, Court Greens, Labumum, Condominium,Comlex, Sushant Lok I, Gurgaon – 122002, Haryana, India

Date of Birth/Age :

08.03.1979

Date of Appointment :

15.11.2012

DIN No.:

00319297

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239MH1997PTC111897

RECKITT PIRAMAL PRIVATE LIMITED

Director

21/01/2002

21/01/2002

-

Active

NO

2

U74999DL1951PLC127062

RECKITT BENCKISER (INDIA) LIMITED

Whole-time director

15/11/2012

21/01/2002

-

Active

NO

3

U25199TN1963PLC004982

TTK PROTECTIVE DEVICES LIMITED

Director appointed in casual vacancy

15/11/2010

15/11/2010

09/11/2012

Active

NO

4

U24232TN1994PLC048002

RECKITT BENCKISER SCHOLL INDIA LIMITED

Director

03/10/2011

15/11/2010

-

Active

NO

5

U65993HR2011PTC042069

Reckitt Benckiser Investments India Private Limited

Director

11/02/2011

11/02/2011

-

Amalgamated

NO

6

U24231HR1980PLC044172

RECKITT BENCKISER HEALTHCARE INDIA LIMITED

Director

15/11/2012

11/04/2011

-

Active

NO

7

U24240MH2011PTC239427

Halite Personal Care India Private Limited

Director

15/06/2011

15/06/2011

29/05/2012

Under liquidation

NO

 

 

Name :

Mr. Parag Agarwal

Designation :

Director

Address :

Apartment 1b, Tower Tg-6, Orchid Gaden, Sun City, Sec – 54, Gurgaon – 122002, Haryana, India

Date of Birth/Age :

19.02.1966

Date of Appointment :

01.01.2013

DIN No.:

02954487

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74999DL1951PLC127062

RECKITT BENCKISER (INDIA) LIMITED

Director

01/01/2013

03/03/2010

-

Active

NO

2

U65993HR2011PTC042069

Reckitt Benckiser Investments India Private Limited

Director

11/02/2011

11/02/2011

-

Amalgamated

NO

3

U24231HR1980PLC044172

RECKITT BENCKISER HEALTHCARE INDIA LIMITED

Director

21/09/2011

11/04/2011

28/06/2013

Active

NO

4

U24240MH2011PTC239427

Halite Personal Care India Private Limited

Director

15/06/2011

15/06/2011

29/05/2012

Under liquidation

NO

5

U24232TN1994PLC048002

RECKITT BENCKISER SCHOLL INDIA LIMITED

Director

03/10/2011

03/10/2011

09/05/2013

Active

NO

 

 

Name :

Mr. Ariadna Granena Aracil

Designation :

Director

Address :

Calle Carme Karr, 14 Bajo 4, Barcelona – 08034, SPAIN

Date of Birth/Age :

23.06.1974

Date of Appointment :

30.09.2014

DIN No.:

02773538

 

 

KEY EXECUTIVES

 

Name :

Mr. Manoj Singh Bisht

Designation :

Company Secretary

Address :

20B, Janta Flats, Vasant Enclave, New Delhi – 110057, India

Date of Birth/Age :

06.01.1988

Date of Appointment :

04.04.2012

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on : 30.09.2014

 

Names of Shareholders

No. of Shares

%age

Reckitt Benckiser PLC

10725120

41.45

Reckitt Benckiser PLC

6060601

23.42

Lancaster Square Holding SL

2393185

9.25

Chander Mohan Sethi

1

0.00

Rajesh Kumar Jha

1

0.00

Sarita William

1

0.00

Ajay Thukral

1

0.00

R and C Nominees Limited (Beneficial Ownership Rests with Reckitt Benckiser PLC)

1

0.00

Lancaster Square Holding SL

6693556

25.87

Total

25872467

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

%age

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

100.00

Total

100.00

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, seller and exporter of drugs and medicines, such as bulk drugs in the form of liquids, ointments, and tablets; denture products; food products, including tea, cashew kernels, and mushrooms; laundry products; household products; aromatic chemicals; and toiletries.

 

 

Products :

  • Liquids
  • Ointments
  • Tablets
  • Denture Products
  • Food Products
  • Tea
  • Cashew Kernels
  • Mushrooms
  • Laundry Products
  • Household Products;
  • Aromatic Chemicals
  • Toiletries.

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Experience :

Not Available

Maximum Limit Dealt :

Not Available

 

 

Customers :

 

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Experience :

Not Available

Maximum Limit Dealt :

Not Available

 

 

No. of Employees :

Not Available

 

 

Bankers :

Banker Name

Not Available

Branch Address

Not Available

Person Name (With Designation)

Not Available

Contact Number

Not Available

Name of Account Holder

Not Available

Account Number

Not Available

Account Since (Date/Year of Account Opening)

Not Available

Average Balance Maintained (If Possible)

Not Available

Credit Facilities Enjoyed (If any)

Not Available

Account Operation

Not Available

Remarks (If any)

Not Available

 

 

 

Auditors :

 

Name :

Gupta Charan Sewak

Chartered Accountant

Address :

Price Waterhouse, Building 8, 7Th and 8th floor Tower B, DLF Cyber city, Gurgaon - 122002, Haryana,

PAN No.:

AAFFP3698A

 

 

Financial Institutions :

Director of Industrial Himachal Pradesh through Member Secretary, SWCA, Parwanoo -173220, Himachal Pradesh, India

 

 

 

 

Holding Company :

  • Reckitt Benckiser plc, UK
  • Lancaster Square Holding SL

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates :

  • Reckitt Benckiser Healthcare India Limited

(CIN No.24231HT1980PLC044172)

 

  • Reckitt Benckiser Scholl India Limited

(CIN No.U24232TN1994PLC048002)

 

 

Subsidiaries :

  • Reckitt Piramal Private Limited
  • Reckitt Benckiser Corporate Services Limited., UK
  • Reckitt and Colman (Overseas) Limited
  • Reckitt Benckiser Healthcare (UK) Limited
  • Reckitt Benckiser (Lanka) Limited
  • Reckitt Benckiser (Lanka) Limited
  • Reckitt Benckiser LLC, USA
  • Reckitt Benckiser Pakistan Limited
  • Reckitt Benckiser Household Products (China) Company Limited
  • Reckitt Benckiser Nigeria Limited
  • Reckitt Benckiser Australia Pty Limited
  • Reckitt Benckiser (Brands) Limited
  • SSL Manufacturing (Thailand) Limited
  • PT. Reckitt Benckiser Indonesia
  • Benckiser Production GmbH, Germany
  • Reckitt Benckiser France SAS
  • Reckitt Benckiser Arabia, FZE, UAE
  • Reckitt Benckiser South Africa (Pty) Limited
  • Reckitt Benckiser (Malaysia) Sdn Bhd
  • Reckitt Benckiser (ENA) B.V

 

 

CAPITAL STRUCTURE

 

As on : 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

35000000

Equity Shares

Rs.10/- each

Rs.350.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

25872467

Equity Shares

Rs.10/- each

Rs.258.725 Million

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

258.725

258.725

258.725

(b) Reserves & Surplus

18082.313

10691.062

6362.452

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

18341.038

10949.787

6621.177

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

535.010

523.933

0.000

(d) long-term provisions

0.000

0.000

543.891

Total Non-current Liabilities (3)

535.010

523.933

543.891

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

6297.169

5794.959

4957.542

(c) Other current liabilities

965.369

802.232

640.036

(d) Short-term provisions

211.785

155.291

203.055

Total Current Liabilities (4)

7474.323

6752.482

5800.633

 

 

 

 

TOTAL

26350.371

18226.202

12965.701

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

2972.731

2235.933

1979.657

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

246.656

241.242

227.760

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

7377.919

7377.919

0.000

(c) Deferred tax assets (net)

148.266

187.029

191.983

(d)  Long-term Loan and Advances

555.708

335.131

274.249

(e) Other Non-current assets

3.256

3.256

3.169

Total Non-Current Assets

11304.536

10380.510

2676.818

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

3665.095

3027.354

3654.114

(c) Trade receivables

1369.538

1278.255

885.249

(d) Cash and cash equivalents

9367.322

2803.026

5219.454

(e) Short-term loans and advances

596.302

715.248

499.320

(f) Other current assets

47.578

21.809

30.746

Total Current Assets

15045.835

7845.692

10288.883

 

 

 

 

TOTAL

26350.371

18226.202

12965.701

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Revenue from Operations

40033.116

35953.294

34934.983

 

Other Income

1075.784

926.450

1229.517

 

TOTAL

41108.900

36879.744

36164.500

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

12957.587

12446.202

12256.175

 

Purchases of Stock-in-Trade

6773.342

6945.183

7922.830

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(296.861)

543.042

(1197.804)

 

Employees benefits expense

1464.699

1411.529

1377.419

 

Other expenses

10528.520

9212.320

8650.069

 

TOTAL

31427.287

30558.276

29008.689

 

 

 

 

 

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

9681.613

6321.468

7155.811

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

301.599

376.010

390.199

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

9380.014

5945.458

6765.612

 

 

 

 

 

Less

TAX

1988.763

1316.151

1382.589

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

7391.251

4629.307

5383.023

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD 

9199.469

5333.790

 0.000

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Transfer to General Reserve

462.931

 

 

Dividend

 

258.725

 

 

Tax on Dividend

 

41.972

 

 

Total

NA

763.628

NA

 

 

 

 

 

 

Balance Carried to the B/S

16590.720

9199.469

5383.023

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

286.246

177.448

 

 

TOTAL EARNINGS

286.246

177.448

NA

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

285.68

178.93

208.06

 

 

KEY RATIOS

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

Net Profit Margin (PAT/Sales)

(%)

18.46

12.88

15.41

 

 

 

 

 

Operating Profit Margin (PBITD/Sales)

(%)

24.18

17.58

20.48

 

 

 

 

 

Return on Total Assets (PBT/Total Assets}

(%)

50.49

57.06

53.93

 

 

 

 

 

Return on Investment (ROI) (PBT/Networth)

 

0.51

0.54

1.02

 

 

 

 

 

Debt Equity Ratio (Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio (Current Asset/Current Liability)

 

2.01

1.16

1.77

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

258.725

258.725

258.725

Reserves & Surplus

6362.452

10691.062

18082.313

Net worth

6621.177

10949.787

18341.038

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

34934.983

35953.294

40033.116

 

 

2.915

11.348

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

34934.983

35953.294

40033.116

Profit

5383.023

4629.307

7391.251

 

15.41%

12.88%

18.46%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

No

24]

Banking facility details

No

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

PERFORMANCE:

 

The trend of delivering consistent growth continues. The net revenue from operations of the company for the year ended 31st march 2014 stood at Rs. 40033.116 Million. The profit have increased at a good rate as compared to the previous year. The profit before tax for the year 2013-2014 stood at Rs. 9380.014 Million and the profit after tax was Rs. 7391.251 Million

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR THE COMPANY

 

 

PRESS RELEASE

 

GOVERNMENT ORDER FORCING COSMETIC FIRMS TO DECLARE ‘NON-VEG PRODUCTS’ UNDER HC SCANNER:

 

New Delhi: The Delhi High Court on Monday sought the Centre's response on pharma major Reckitt Benckiser's plea challenging a government notification mandating that every pack of cosmetics should indicate whether it has any ingredient of animal origin.

 

A bench of Chief Justice G Rohini and Justice RS Endlaw issued notice to the government and sought its response by 18 May on Reckitt Benckiser's plea that the 16 June, 2014 notification of Department of Consumer Affairs is contrary to provisions of the Drugs and Cosmetics Act.

 

The department has issued the notification under the Legal Metrology Act, while the company has claimed that the issue falls under the scope of the Drugs and Cosmetics Act.

 

The notification mandates that packages of cosmetics and toiletries like shampoos, toothpastes and soaps should bear a red/brown dot for non-vegetarian origin and green dot for vegetarian.

 

The company contended that Supreme Court in 2013 had held that without a "fruitful consideration" with Drugs Technical Advisory Board (DTAB) no amendment can be made or suggested to change label of drugs.

 

It also contended that DTAB had not been agreeable to indicating, on labels of cosmetics, whether source of the product was vegetarian or non-vegetarian, "possibly because unlike food, cosmetics and toiletries are not for oral consumption and are manufactured from hundreds of ingredients whose source would not possible to ascertain".

 

The company, in its plea, has sought quashing of the notification saying it is "arbitrary, irrational and discriminatory".

 

It has also said that the Bombay High Court in a similar plea by an association of manufacturers of cosmetics and toiletries had directed the government not to take "coercive steps" against the petitioner firms for not declaring whether their products contained any ingredient of animal origin.

 

PROJECT SUPERCHARGE: RECKITT BENCKISER TO RESTRUCTURE, CUT COSTS AMID SLOWING SALES:

 

NEW DELHI: Reckitt Benckiser, maker of Dettol soap, Lizol floor cleaner and Veet hair remover, will restructure operations and prune costs to deal with slowing sales across markets, including India, the company said. This will include less travel by executives, manufacturing rationalisation and even reduced use of office stationery — all as part of Project Supercharge that was announced by the British consumer goods company's CEO Rakesh Kapoor late last week to drive margin expansion and cost savings of Rs.100.150 million in 2015.

 

Ageographic restructuring will reduce business clusters to two from three and make reporting structures linear, accelerate decision making and allow better co-ordination. India, under Reckitt Benckiser's (RB's) Developing Markets group, will be part of the cluster that clubs Latin America and Asia with the Middle East and Africa. RB India did not specify how the reporting would change. India has thus far been regional headquarters for Southeast Asia, covering 12 nations, including Singapore, Thailand and Malaysia, with CM Sethi heading this cluster as senior vice-president.

 

RB India, along with other consumer goods companies, has seen growth slowing as customers have been delaying purchases or switching to smaller packs and lower-priced products as they cope with economic uncertainty. Sales rose 11% to about Rs 4,000 crore in FY14, compared with 20% in previous years.

"LAPAC (Latin America and Asia Pacific) experienced a slower year in 2014 driven by slower market conditions in Brazil and Southeast Asia, in particular India, Indonesia and Thailand," Kapoor's statement had said. He expects 2015 to be similar to last year, with sales being hurt by emerging market deceleration.

 

Without disclosing details, the firm said it has identified areas of expenditure with "substantial opportunities for improvement" and that these would be across manufacturing, travel, operations and so on.

 

RB India's spokesperson said in response to ET's query: "With Project Supercharge, we aim to create a simpler and more agile organisation and reduce costs and drive efficiency to maintain our operating model of outperformance."

 

 

RECKITT BENCKISER LAUNCHES DETTOL KITCHEN GEL:

 

NEW DELHI: Consumer goods major Reckitt Benckiser today said it has entered a new segment with the launch of 'Dettol Kitchen', a new range of disinfectant kitchen gel.

 

Dettol Kitchen marks Dettol's entry into a new segment after liquid hand wash in 1992, Reckitt Benckiser said in a statement.

 

"...kitchen sponges are known to be a breeding ground for germs. It made complete sense to extend this promise of Dettol's germ protection to kitchen by providing a single solution for truly healthy kitchen," Reckitt Benckiser Senior Vice President-South East Asia Chander Mohan Sethi said.

 

Reckitt Benckiser's markets various brands including StrepsilsDurex, Clearasil, Harpic among others. 

 

 

 

 

 

RECKITT BENCKISER PLANS EXPERTS COUNCIL FOR ‘BANEGA SWACHH’ CAMPAIGN: OFFICIAL:

 

NEW DELHI: Reckitt Benckiser is in the process of setting up a council of experts comprising of corporates and public sector officials to track progress of its 'Banega Swachh India' campaign, a top official at the UK-based consumer goods multinational said.

 

"We need accountability in implementation (of the campaign)," Rajiv Chandra, senior VP, global category officer — hygiene, at Reckitt Benckiser told ET in an exclusive interaction.

 

Chandra, who's based in the UK and was on a visit to India last week, said the council will define a health and hygiene index and focus on tracking and reporting mechanism for the programme. He declined to name any likely member, saying the firm is in the process of finalising partners.

 

Reckitt Benckiser (RB) has committed Rs 100 crore for the campaign for five years. The campaign is expected to have a rub-off on its flagship anti-germ brand Dettol, in addition to its other hygiene brands such as Harpic and Lizol. "In the end, when we have consumers using our brands, it does impact the business," Chandra said.

 

Nitish Kapoor, managing director at RB India, said the expert council will comprise of individuals from corporates, public sector and development sector, research sector with knowledge and experience in devising tracking and reporting mechanisms for programmes of such scale. RB has, so far, named 'swachh ambassadors' — including cricketer Sachin Tendulkar, actress Priyanka Chopra and advertising veteran Prasoon Joshi — to generate awareness about the campaign. Actor Amitabh Bachchan is the face of the campaign.

 

The firm is hopeful of launching a series of bottom-of-pyramid products in the hand-wash and hygiene space, to coincide with its cleanliness campaign. These products, which may be under the umbrella of existing brands Dettol and Harpic, are expected to be launched over the next few months, Kapoor said.

 

RECKITT BENCKISER, DABUR LEGAL SPAT ESCALATES OVER PUDIN HARA ADS

 

NEW DELHI: Consumer goods firm Reckitt Benckiser (RB), which makes Dettol antiseptic and Cherry Blossom shoe polish, has escalated its legal spat with Vatika shampoo maker Dabur over their respective antacid brands Gaviscon and Pudin Hara. Reckitt Benckiser had dragged Dabur to Delhi High Court alleging that the ads for Dabur's Pudin Hara lemon fizz drink had "infringed its trademark and copyright".

 

The court has passed a judgement in favour of Dabur last month stating that the firm is free to run the ads for Pudin Hara lemon fizz, against which Reckitt has now filed an appeal.

 

According to the court order, a copy of which ET has reviewed, RB is not entitled to temporary injunction in the case. The court has, however, said that if there is any modification in the television commercial, Dabur would need to take necessary permission from the court. The central character in the dispute is a fire fighter theme. RB alleged that the theme of firemen has infringed 'its trademark and copyright'.

According to the court, depiction of flames being extinguished by water or medicine cannot be monopolised by any firm.

 

"This is a well-reasoned judgement and after extensive discussion, the court has concluded that Reckitt Benckiser has failed to make out a prima facie case for temporary injunction either on the grounds of infringement of trademark, copyright or passing off," Sudhir Makkar, advocate representing Dabur, said in an email.

 

An email sent to Reckitt Benckiser did not elicit any response till the time of going to press. While Gaviscon is a power brand of the British firm, Pudin Hara is one of Dabur's top brands and occupies leadership position in the liquid antacid space. While no syndicated data is available for antacids, industry estimates put the category's value at around Rs 1,000 crore.

 

The category is broadly split three ways between GlaxoSmith-Kline's Eno, Dabur's Pudin Hara in liquid and pill form, and tablets/liquids like Digene and Gelusil. Together, these brands would account for anywhere between 90% and 95% of the market with Eno as the biggest brand.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.60

UK Pound

1

Rs.92.95

Euro

1

Rs.68.14

 

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

SUJ


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILITY 

1~10

7

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

8

--CREDIT LINES

1~10

8

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

69

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.